Novel Biological Therapies for Severe Asthma Endotypes

Novel Biological Therapies for Severe Asthma Endotypes

Severe asthma comprises several heterogeneous phenotypes, underpinned by complex pathomechanisms known as endotypes. The latter are driven by intercellular networks mediated by molecular components which can be targeted by specific monoclonal antibodies. With regard to the biological treatments of e...

Full description

Bibliographic Details
Main Authors: Corrado Pelaia, Giulia Pelaia, Claudia Crimi, Angelantonio Maglio, Anna Agnese Stanziola, Cecilia Calabrese, Rosa Terracciano, Federico Longhini, Alessandro Vatrella
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Biomedicines
Subjects:
type 2 severe asthma
monoclonal antibodies
IgE
pro-inflammatory cytokines
alarmins
Online Access:https://www.mdpi.com/2227-9059/10/5/1064

Similar Items

Similar Items